The C2 subtype of glioblastoma with IDH mutation has poor survival outcomes analogous to those without IDH mutation, whereas the C1 subtype of glioblastoma with IDH mutation has significantly better survival outcomes (Figures 4A, B). This evidence concerns the gene IDH1 and glioblastoma.